Perfil
Jason Paragas is currently the Chief Executive Officer at DVLP Medicines.
He is also a Director at Probius DX, Inc. and a Venture Partner at Social Impact Capital, Inc. Mr. Paragas holds a doctorate degree from Icahn School of Medicine at Mount Sinai, which he obtained in 2001.
Cargos activos de Jason Paragas
| Empresas | Cargo | Inicio |
|---|---|---|
Probius DX, Inc.
 Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Director/Miembro de la Junta | - |
Social Impact Capital, Inc.
 Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Inversor de Capital Privado | 01/04/2021 |
Formación de Jason Paragas.
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Probius DX, Inc.
Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Health Technology |
Social Impact Capital, Inc.
Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
- Bolsa de valores
- Insiders
- Jason Paragas
